What Is Going On At Axovant Sciences? [Seeking Alpha]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: Seeking Alpha
Summary On February 12, 2018, Axovant Sciences ( AXON ) issued a press release noting changes to the management team and Board of Directors. Dr David Hung retired as CEO and Dr Pavan Cheruvu took his place, among other changes. Three and a half months of radio silence followed. What broke the silence? Another press release on May 29 noting additions to the management team and organizational restructuring. Things got interesting on June 6, when AXON reported it had licensed a gene therapy for Parkinson’s disease from Oxford BioMedica and of course made additional management changes. While investors can now be confident that AXON likes to make changes to management, investor confidence that AXON can develop a successful drug may be lacking given failures in 2017 and early 2018. What is in the AXON pipeline? In 2017, AXON was developing intepirdine, nelotanserin and RVT-103/RVT-104. Intepirdine has failed in Alzheimer's disease and dementia with Lewy bodies (DLB) an
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise Insiders Placed Bullish Bets Worth US$8.74m [Yahoo! Finance]Yahoo! Finance
- Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at JPMorgan Chase & Co. from $330.00 to $365.00. They now have an "overweight" rating on the stock.MarketBeat
- Axon Enterprise (AXON) Banks on Solid Product Demand Amid Risks [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at Needham & Company LLC from $315.00 to $400.00. They now have a "buy" rating on the stock.MarketBeat
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEFA14A
- 4/2/24 - Form 4
- AXON's page on the SEC website